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Abstract
Assessing complementary and alternative medicine (CAM) use remains difficult due to many problems, not the
least of which is defining therapies and modalities that should be considered as CAM. Members of the Inter-
national Society for Complementary Medicine Research (ISCMR) participated in a Delphi process to identify a
core listing of common CAM therapies presently in use in Western countries. Lists of practitioner-based and self-
administered CAM were constructed based on previous population-based surveys and ranked by ISCMR re-
searchers by perceived level of importance. A total of 64 (49%) ISCMR members responded to the first round of
the Delphi process, and 39 of these (61%) responded during the second round. There was agreement across all
geographic regions (United States, United Kingdom, Canada, and Western Europe) for the inclusion of herbal
medicine, acupuncture, homeopathy, Traditional Chinese Medicine (TCM), chiropractic, naturopathy, osteop-
athy, Ayurvedic medicine, and massage therapy in the core practitioner-based CAM list, and for homeopathy
products, herbal supplements, TCM products, naturopathic products, and nutritional products in the self-
administered list. This Delphi process, along with the existing literature, has demonstrated that (1) separate lists
are required to measure practitioner-based and self-administered CAM; (2) timeframes should include both ever
use and recent use; (3) researchers should measure and report prevalence estimates for each individual therapy
so that direct comparisons can be made across studies, time, and populations; (4) the list of CAM therapies
should include a core list and additionally those therapies appropriate to the geographic region, population, and
the specific research questions addressed, and (5) intended populations and samples studied should be defined
by the researcher so that the generalizability of findings can be assessed. Ultimately, it is important to find out
what CAM modality people are using and if they are being helped by these interventions.
Introduction
Complementary and alternative medicine (CAM)increasingly has an established place in integrated health
care and health care research. CAM modalities and regimes are
more widely available in primary medical care and through the
services of private CAM practitioners in all Western industri-
alized nations, and are the main health care technologies in
some third world environments where they are considered
mainstream and not CAM. The most frequent use in the West
may well be self-prescribed or recommended via nonmedical
referral systems. Because the use of CAM has many ramifica-
tions that extend beyond medicine and public health to the
health and wellbeing of individuals in every community in the
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world, it becomes increasingly important to consider how it
may best be defined in order to evaluate prevalence of use.
Prevalence and incidence estimates of CAM use are fre-
quently beset with problems related to standardization, as
there is difficulty in defining which therapies and modalities
should be considered as CAM. This can invalidate data
comparison and interpretation across studies. Despite these
problems, many useful surveys of CAM prevalence have
been conducted. Barnes et al. showed age-adjusted preva-
lence of CAM use reported in population-based studies con-
ducted in the United States between 1990 and 2004 (Fig. 1).1
As indicated by Barnes et al., most of these surveys asked
participants to indicate whether they used one or more items
from a list of CAM interventions or therapies, and the lists
varied considerably among the surveys. This research has
underlined the difficulty of comparing variables in one survey
with another and re-emphasizes the need for surveys to in-
corporate standardized methods and definitions.2–7
In a systematic review of the prevalence of CAM use,
Ernst summarized the available data among random or
representative samples of the general population.6 He con-
cluded that the true prevalence of use of CAM remains un-
certain. In a more recent publication, Ernst calls for greater
attention to methods when conducting surveys of CAM
prevalence, including development and use of question-
naires that are properly validated.7
Thomas and colleagues discuss the difficulties of mea-
suring CAM as a unified concept, as different researchers
include different therapies in their definition of CAM.5 There
appears to be a tradeoff between the accuracy of estimates
obtained and their comprehensiveness. Lists of CAM thera-
pies have been developed and can be used to provide a
framework for the selection of a core CAM list for future
surveys.8–14 Specific guidelines have been proposed by
Harris and Rees to standardize the measurements of CAM
prevalence such as timeframe, distinguishing between prac-
titioner-led and self-medicated or over-the-counter use, and
definition of what constitutes a CAM therapy.4 A formal
universal definition may not be either possible or adequate.
Treatments considered to be CAM vary depending on dis-
ability or disease, population group, country, race=ethnicity,
and the specific research question posed. In addition, over
time, treatments once considered to be CAM have entered
into the mainstream. Accepting these limitations, it may still
be feasible to define a standardized set of common treat-
ments that could be used to enable comparisons among
surveys. This core list could be supplemented with addi-
tional CAM therapies to take into account disease-specific,
country-specific, or population-specific CAM therapies.
This study describes the results of a Delphi process de-
signed to develop a common core list of CAM therapies to be
used as a baseline in surveys to determine CAM prevalence.
The main aim was to identify an agreed core listing of
common CAM therapies presently in use across different
Western countries.
Materials and Methods
Members of the International Society for Complementary
Medicine Research (ISCMR, www.iscmr.org) from Western
countries agreed to take part in a Delphi process. The ISCMR
board of directors sent out an introductory e-mail describing
the project and asking members to participate in a Delphi
process. The Delphi process is a technique used to elicit
opinions and gather a group response from a panel of ex-
perts in an anonymous way that minimizes effects related to
group interaction.15,16 Elements critical to the process include
feedback in the form of individual contributions or re-
sponses, assessment of the group opinion, opportunity for
individuals to revise their original responses following the
initial assessment of group opinion, and guaranteed ano-
nymity for the individuals who participate in the process.
An initial list of CAM therapies was developed based on
previous population-based surveys.7–14,17,18 Repeated e-mail
invitations were sent to ISCMR members from Western
countries (N¼ 130) to request participation, and news items
informing the members about the proposed Delphi process
were printed in the ISCMR newsletter to maximize partici-
pation. ISCMR members from Western countries who elec-
ted to participate responded to the initial list of CAM
therapies, ranking them individually and anonymously as
1¼very important, 2¼ somewhat important, or 3¼ not
important for inclusion in the core list. Two lists were pro-
vided, which were divided into practitioner-based and
FIG. 1. Based on (A) National Center for Health Statistics.
2002 National Health Interview Survey (NHIS). (B) 2002
NHIS excluding megavitamin therapy. (C) 2002 NHIS ex-
cluding prayer for health reasons. (D) Eisenberg DM, Davis
RB, Ettner SL, et al. Trends in alternative medicine use in the
United States, 1990–1997: Results of a follow up national
survey. JAMA 1998;280:1569. (E) Astin JA. Why patients use
alternative medicine: Results of a national study. JAMA
1998;279:1548. Eisenberg DM, Kessler RC, Foster C, et al.
Unconventional medicine in the United States: Prevalence,
costs, and patterns of use. N Eng J Med 1993;328:246. (F) Ni
H, Simile C, Hardy AM. Utilization of complementary and
alternative medicine by United States adults: Results from
the 1999 National Health Interview Survey. Med Care
2002;40:353–358. (G) Oldendick R, Coker AL, Wieland D,
et al. Population-based survey of complementary and alter-
native medicine usage, patient satisfaction, and physician in-
volvement. South Med J 2000;93:375. (H) Rafferty AP, McGee
HB, Miller CE, Reyes M. Prevalence of alternative medicine
use: State-specific estimates from the 2001 Behavioral Risk
Factor Surveillance System. Am J Public Health 2002;92:1598.
(I) Paramore LC. Use of alternative therapies. Estimates from
the 1994 Robert Wood Johnson Foundation National Access to
Care Survey. J Pain Symptom Manage 1997;13:83. CAM,
complementary and alternative medicine.
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self-administered CAM, with an opportunity to add items to
the lists. Two Delphi rounds were conducted between De-
cember 2004 and May 2005 via e-mail following established
Delphi process protocols.15,16 At each round, CAM therapies
with an overall mean score 2.0 across all respondents were
removed from the list. After each round the CAM therapies
were placed in rank order and the results were shown to the
panel at the second round. Disagreements across the geo-
graphic areas were reported if at least one geographic area
ranked a therapy as 2.0 and at least one geographic area
ranked the same therapy as <2.0. A decision was made to
discontinue the Delphi process after two rounds and to re-
port the areas of both agreement and disagreement by geo-
graphic region with the realization that geographic-related
responses may be important to acknowledge in core lists of
CAM along with a universal core list. An opportunity was
provided for the reviewers to insert qualitative remarks, and
these remarks were taken into account in the revisions of lists
between the first and second rounds of the Delphi process.
Results
A total of 64 of the 130 (49%) ISCMR members from
Western countries responded to the first round of the Delphi
process. In the second round, 39 members (61%) who par-
ticipated in round one responded to the survey (Table 1).
Analysis comparing responders to non-responders showed
that the qualifications of responders were similar to those of
non-responders. Those who responded to the Delphi process
were slightly more likely to be professors and researchers at
the Ph.D. level. CAM therapies included in lists for both
round 1 and round 2 of the Delphi process are summarized
in Table 2. Qigong was the only therapy not included in the
core list that was added by respondents and carried through
to the second round of the Delphi process, with overall
support for inclusion.
Practitioner-based CAM
Practitioner-based CAM therapies that were considered
important overall (mean< 2.0) for the core list include acu-
pressure, acupuncture, anthroposophical medicine, aroma-
therapy, Ayurvedic medicine, Traditional Chinese Medicine
(TCM), chiropractic care, guided imagery=relaxation ther-
apy, herbal medicine=medical herbalism=phytotherapy,
Table 1. ISCMR Respondents by Geographic Region
Region Round 1 (n¼ 64) Round 2 (n¼ 39)
United States 29% 24%
United Kingdom 25% 33%
Canada 22% 17%
Western Europe 17% 19%
Response rate 64=130 (49%) 39=64 (61%)
ISCMR, International Society for Complementary Medicine
Research.
Table 2. CAM Therapies Included in Practitioner-Based and Self-Medication Lists
from Rounds 1 and 2 of the Delphi Process
Practitioner-based list Round 1 Round 2 Self-medication list Round 1 Round 2
Acupressurea   Acupressure 
Acupunctureb  
Alexander technique  Alexander technique 
Anthroposophical medicinea   Anthroposophical medicine 
Aromatherapya   Aromatherapy 
Ayurvedic medicineb   Ayurvedic medicinea  
Bioelectromagnetic therapies  Bioelectromagnetic therapies 
Traditional Chinese Medicineb   Traditional Chinese Medicine productsb  
Chiropractic careb  
Flower essences (e.g., Bach)  Flower essences (e.g., Bach) 
Guided imagery=relaxation therapya   Guided imagery=relaxation therapya  
Healing=Reiki 




Homeopathya   Homeopathy productsb  
Hypnotherapya  
Massage therapyb  
Meditation, any type  Meditation, any typea  
Naturopathyb   Naturopathic productsb  
Nutritional therapya   Nutritional productsb  
Osteopathyb  
Qigong  Qigonga  
Prayer 
Reflexology  Reflexology 
T’ai chi  T’ai chia  
Yogaa   Yogaa  
aOverall agreement for the core list but disagreement by geographic regions.
bAgreement for the core list overall and across geographic regions.
CAM, complementary and alternative medicine.
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homeopathy, hypnotherapy, massage therapy, naturopathy,
nutritional therapy, osteopathy, and yoga. Table 3 shows the
agreement (mean< 2.0) across geographic regions for the
practitioner-based CAM core list. There was agreement
across all geographic regions for the inclusion of acupunc-
ture, Ayurvedic medicine, TCM, chiropractic care, herbal
medicine (also described as herbalism or phytotherapy),
homeopathy, massage therapy, naturopathy, and osteopathy
in the core CAM list. Respondents from the U.S., U.K., and
Canada were more likely to rank nutritional therapy as an
important practitioner-based CAM (Table 4). Respondents
from Western European countries ranked anthroposophical
medicine as an important CAM, and this differed from its
ranking by respondents from all other geographic regions.
Self-administered CAM
Self-administered CAM therapies that were considered
important overall (mean< 2.0) for the core list include Ayur-
vedic medicine, TCM products, guided imagery=relaxation
therapy, herbal supplements, homeopathic products, medi-
tation, naturopathic products, nutritional products, qigong, t’ai
chi, and yoga. There was agreement (mean< 2.0) across geo-
graphical regions regarding the importance of TCM products,
homeopathy products, herbal supplements, naturopathic
products, and nutritional products (Table 5). Respondents
from the U.S. and U.K. were more likely to agree about the
importance of guided imagery=relaxation, qigong, and yoga
(Table 6). T’ai chi was considered important by U.K. respon-
dents and Western European respondents, while respondents
from Canada and Europe were more likely to agree about the
importance of Ayurvedic medicine.
Comments from respondents
Respondents took advantage of the opportunity to submit
comments and suggestions which indicated the importance
of geographic area in determining the importance of CAM
therapies. For example, chiropractic therapies, anthro-
posophical medicine, and osteopathy are considered CAM in
some regions, but mainstream medicine in others. There is a
need for the core list to include the opportunity for geo-
graphic-specific therapies and researcher-specific therapies
that are disease-specific.
Many respondents commented on the inclusion of any
systems of medicine in the self-administered core list, due to
the concern that individuals could not use systems of med-
icine without a practitioner. The presence of a practitioner
was considered by many respondents to be essential to the
use of systems of medicine and modalities of CAM, although
most agreed that using products associated with systems of
medicine (such as Chinese herbs) without a practitioner may
be considered a self-administered CAM practice. There was
further debate about what might be included in a system of
medicine used in a core list of CAM. Does TCM include
qi gong and t’ai chi, and how is this classified on the practi-
tioner list versus the self-administered core list?
Discussion
The results of the Delphi process showed more agreement
overall and across geographic regions for practitioner-based
CAM compared with self-administered CAM. Respondent
comments pointed to the difficulties involved in classifying
self-administered aspects of CAM that may not be possible
without the advice of a practitioner.
Table 3. Practitioner-Based CAM Agreement by Region in Round 2
Practitioner-based CAM United States (n¼ 10) United Kingdom (n¼ 14) Canada (n¼ 7) Western Europe (n¼ 8)
Acupuncture 1.1 0.3 1.1 0.3 1.1 0.4 1.1 0.4
Ayurvedic medicine 1.3 0.5 1.7 0.8 1.3 0.5 1.6 0.9
Traditional Chinese Medicine 1.1 0.3 1.0 0.01 1.0 0.01 1.3 0.7
Chiropractic care 1.2 0.4 1.1 0.4 1.3 0.8 1.4 0.5
Herbal medicine=herbalism 1.0 0.01 1.1 0.3 1.0 0.01 1.0 0.01
Homeopathy 1.4 0.7 1.1 0.3 1.0 0.01 1.3 0.5
Massage therapy 1.6 0.5 1.6 0.7 1.4 0.8 1.5 0.5
Naturopathy 1.2 0.4 1.5 0.7 1.0 0.01 1.6 0.5
Osteopathy 1.5 0.5 1.1 0.3 1.7 1.0 1.5 0.5
All figures are mean standard deviation. Responses according to a four-point scale of 1¼very important, 2¼ somewhat important,
3¼not important.
CAM, complementary and alternative medicine.
Table 4. Practitioner-Based CAM Disagreement by Region in Round 2
Practitioner-based CAM United States (n¼ 10) United Kingdom (n¼ 14) Canada (n¼ 7) Western Europe (n¼ 8)
Acupressure 2.2 0.08 2.0 0.8 1.7 0.05 1.8 0.05
Anthroposophical medicine 2.1 0.6 2.2 0.8 2.2 0.8 1.1 0.4
Aromatherapy 2.2 0.7 1.6 0.6 1.7 0.08 2.1 0.6
Guided imagery=relaxation 1.5 0.7 1.8 0.08 2.3 0.08 2.0 0.5
Hypnotherapy 1.8 0.8 1.6 0.7 2.3 1.0 2.3 0.5
Nutritional therapy 1.2 0.6 1.4 0.7 1.4 0.08 2.0 0.8
Yoga 1.9 0.0 1.8 0.6 2.4 0.5 1.9 0.6
All figures are mean standard deviation. Responses according to a four-point scale of 1¼very important, 2¼ somewhat important,
3¼not important.
CAM, complementary and alternative medicine.
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Difficulties arose in classifying certain therapies, such as
herbal medicine, nutritional therapy, and massage therapy.
These therapies include a broad range of components that
may have different meanings and interpretations overall and
across geographical areas. The controversy about self-use of
systems of medicine needs further discussion: The question
is whether or not an individual can use a system of medicine
without a practitioner. For the most part, individuals prob-
ably do not use whole systems of CAM without a practi-
tioner, but instead use components or products, such as
acupressure, herbal medicine, or Ayurvedic cooking.
Questions remain regarding whether or not systems of
CAM should be separated from their methods or practices
within the practitioner list. Most respondents agreed that
they should be listed separately. A few respondents also
debated the meaning of ‘‘practitioner’’ within CAM. For ex-
ample, is it important to differentiate according to level of
knowledge or try to measure skill in some way? Does it
matter for prevalence measures if the practitioner is skilled?
How do we differentiate between a well-educated consumer
and an unskilled practitioner? CAM is not static; therapies
currently considered to be CAM may become a part of
mainstream medicine over time. For example, should herbal
medicine, phytotherapy, osteopathy, or nutritional therapy
be considered CAM or mainstream? Individual therapies can
also be a part of more than one system—herbs are part of
naturopathy, TCM, and Ayurvedic medicine.
There are limitations to this Delphi process. The compiled
lists for practice-based and self-administered CAM are not
representative of all English-speaking countries. New Zeal-
and and Australia are not represented. Although opinions
reflect the expertise of members of the ISCMR, not all
members participated in the process. Further, the opinions of
the respondents from ISCMR are not necessarily generaliz-
able to all CAM researchers.
Guidelines exist for constructing surveys to measure the
prevalence of CAM. This Delphi process, in accord with the
existing literature, has demonstrated that:
(1) separate lists are required to measure practitioner-
based and self-administered CAM;
(2) timeframes should include both ever use and recent
use and include consideration of recall bias issues;
(3) researchers should measure and report prevalence esti-
mates for each individual therapy so that direct compar-
isons can be made across studies, time, and populations;
(4) the list of CAM therapies should include a core list and,
additionally, those therapies appropriate to the geogra-
phic region, population, and the specific research ques-
tions addressed (individual researchers may decide it is
important to collect information on all therapies being
used by the individual, irrespective of the classification);
(5) the intended populations and samples studied should
be defined by the researcher so that the generalizability
of findings can be assessed.
Ultimately, it is important to find out what CAM people
are using and if they are being helped.
Conclusions
We have presented the initial development of an interna-
tional core list of CAM that can be used across Western countries
to measure prevalence of use. The next steps involve continued
dialogue among CAM practitioners, researchers, and users to
further define a usable list using these guidelines and then
validating the resulting definitions in differing populations.
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Table 5. Self-Administered CAM Agreement by Region in Round 2
Self-administered CAM United States (n¼ 10) United Kingdom (n¼ 14) Canada (n¼ 7) Western Europe (n¼ 8)
TCM products 1.8 1.0 1.5 0.5 1.3 0.5 1.2 0.4
Homeopathy products 1.6 0.07 1.3 0.5 1.2 0.4 1.3 0.5
Herbal supplements 1.6 0.9 1.3 0.7 1.2 0.4 1.8 0.4
Naturopathic products 1.9 1.0 1.5 0.7 1.2 0.4 1.7 0.5
Nutritional products 1.6 0.7 1.5 0.8 1.5 0.7 1.7 0.8
All figures are mean standard deviation. Responses according to a four-point scale of 1¼very important, 2¼ somewhat important,
3¼not important.
CAM, complementary and alternative medicine; TCM, Traditional Chinese Medicine.
Table 6. Self-Administered CAM Disagreement by Region in Round 2
Self-administered CAM United States (n¼ 10) United Kingdom (n¼ 14) Canada (n¼ 7) Western Europe (n¼ 8)
Ayurvedic medicine 2.0 1.0 1.8 0.9 1.4 0.6 1.5 0.8
Guided imagery=relaxation 1.6 0.7 1.8 0.7 2.5 0.6 1.8 0.8
Meditation 1.6 0.9 1.5 0.5 2.2 1.0 1.8 0.8
Qigong 1.9 0.6 1.8 0.6 2.3 0.5 1.7 0.8
T’ai chi 2.1 0.6 1.7 0.5 2.3 0.5 1.7 0.8
Yoga 1.6 0.7 1.6 0.5 2.3 0.8 1.7 0.8
All figures are mean standard deviation. Responses according to a four-point scale of 1¼very important, 2¼ somewhat important,
3¼not important.
CAM, complementary and alternative medicine.
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